These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11030166)

  • 1. Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barré syndrome. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Espérou H; Jars-Guincestre MC; Bolgert F; Raphaël JC; Durand-Zaleski I
    Intensive Care Med; 2000 Aug; 26(8):1094-100. PubMed ID: 11030166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma exchange for Guillain-Barré syndrome.
    Raphaël JC; Chevret S; Hughes RA; Annane D
    Cochrane Database Syst Rev; 2002; (2):CD001798. PubMed ID: 12076424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange for Guillain-Barré syndrome.
    Raphaël JC; Chevret S; Hughes RA; Annane D
    Cochrane Database Syst Rev; 2001; (2):CD001798. PubMed ID: 11406009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-minimization analysis in the Indian subcontinent for treating Guillain Barre Syndrome patients with therapeutic plasma exchange as compared to intravenous immunoglobulin.
    Maheshwari A; Sharma RR; Prinja S; Hans R; Modi M; Sharma N; Marwaha N
    J Clin Apher; 2018 Dec; 33(6):631-637. PubMed ID: 30329175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Ann Neurol; 1997 Mar; 41(3):298-306. PubMed ID: 9066350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2001; (2):CD002063. PubMed ID: 11406030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Guillain-Barré syndrome: a cost-effectiveness analysis.
    Nagpal S; Benstead T; Shumak K; Rock G; Brown M; Anderson DR
    J Clin Apher; 1999; 14(3):107-13. PubMed ID: 10540364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exchange in Guillain-Barré syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Ann Neurol; 1992 Jul; 32(1):94-7. PubMed ID: 1642477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2010 Jun; (6):CD002063. PubMed ID: 20556755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
    Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the adult Guillain-Barré syndrome: indications for plasma exchange.
    Raphael JC; Chevret S; Auriant I; Sharshar T; Bouget J; Bolgert F
    Transfus Sci; 1999 Feb; 20(1):53-61. PubMed ID: 10621561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Treatment Strategy for Severe Guillain-Barré Syndrome: Zipper Method.
    Kesici S; Tanyıldız M; Yetimakman F; Bayrakci B
    J Child Neurol; 2019 Apr; 34(5):277-283. PubMed ID: 30696330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002063. PubMed ID: 16437439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA; Raphaël JC; Swan AV; Doorn PA
    Cochrane Database Syst Rev; 2004; (1):CD002063. PubMed ID: 14973982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and cost effectiveness of current therapies in Guillain Barre syndrome.
    Mehndiratta MM; Chowdhury D; Goel V
    J Assoc Physicians India; 2001 Apr; 49():459-69. PubMed ID: 11762620
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome.
    Ann Neurol; 1987 Dec; 22(6):753-61. PubMed ID: 2893583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guillain-Barré syndrome: epidemiological, clinical and therapeutic insight].
    Raphaël JC; Sharshar T
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S35-40. PubMed ID: 10896987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present treatment of Guillain-Barre syndrome].
    Raphaël JC
    Bull Acad Natl Med; 2004; 188(1):87-94; discussion 94-5. PubMed ID: 15368928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute phase reactant, fibrinogen, as a guide to plasma exchange therapy for acute Guillain-Barré syndrome.
    Sanjay R; Flanagan J; Sodano D; Gorson KC; Ropper AH; Weinstein R
    J Clin Apher; 2006 Jul; 21(2):105-10. PubMed ID: 16342192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.